Systemic inflammatory response: Definitions, inflammatory markers and therapeutic possibilities;Respuesta inflamatoria sistémica: Definiciones, marcadores inflamatorios y posibilidades terapéuticas

Medicina Intensiva

Volumn 24, Issue 8, 2000, Pages 361-370

  Garcia de Lorenzo y Mateos A ^a   Lopez Martinez J ^b   Sanchez Castilla M ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Unidad de Cuidados Intensivos   (Spain)

^c HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Acute phase reactants; CARS; Inflammatory markers; Multysystemic dysfunction syndrome; SIRS

Indexed keywords

ARTICLE; HEMOFILTRATION; HORMONAL REGULATION; LIPID METABOLISM; MEDIATOR RELEASE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0034515725     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(00)79623-9     Document Type: Review

References (87)

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
2. The natural history of the systemic inflammatory response syndrome (SIRS). A pospective study
3. Dear SIRS. I'm sorry to say that I don't like you
4. Mechanisms of immune suppression in critically ill patients
5. Inflammatory cell activation in sepsis
6. Sir Isaac Newton, sepsis, SIRS and CARS
7. Sepsis: A new hypothesis for pathogenesis of the disease process
8. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Horizons in Trauma Surgery
9. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome
10. Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome
11. Stimulus-dependent production of cytokines and pterins by peripheral blood mononuclear cells
12. Tumor necrosis factor: An updated review of its biology
13. Interactions among proinflammatory cytokines and the classic-endocrine system in sepsis and inflammatorion
14. Role of tumor necrosis factor-alfa in disease states and inflammation
15. Elevated plasma levels of soluble tumor necrosis factor (sTNFRp60) reflect severity of acute pancreatitis
16. Soluble TNF recpetor: What is the significance
17. Interleukin-1 beta in pleural fluids of different etiologies. Its role as inflammatory mediator in empyema
18. Time course of cytokine levels in sepsis
19. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality
20. Circulating soluble interleukine-2 receptor alpha and beta chain inflammatory bowel disease
21. Association of interleukin-4 plasma levels with traumatic injury and clinical course
22. Interleukin-10 production during septicaemia
23. Inflammatory and nitric oxide responses in pediatric sepsis and organ failure
24. Tolerance and susceptibility to bacterial endotoxins
25. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators
26. Increased plasma concentration of sl-CAM-1, sVCAM-1 and s-ELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity
27. Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver and small bowel-plus-liver transplant recipients
28. Leukocyte activation in the peripheral blood of patients with cirrhosis of liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction
29. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction
30. Certain batches of albumin solutions influence the expression of endothelial cell adhesion molecules
31. Circulating intercellular adhesion molecule-1 (sICAM-1) as an early and sensitive marker for virus-induced T cell activation
32. Increased plasma concentrations of circulating intercellular adhesión molecule-1 (cICAM-1) in patients with necrotizing pancreatitis
33. Interleukin-1 blockade attenuates release and dysregulation of the hemostatic mechanism during human sepsis
34. Release of interleukin-6 and activation of complement during and after pediatric cardiopulmonary bypass. Effect of autotransfusion of shed mediastinal blood and ultrafiltration
35. Hemofiltratiion in human sepsis: Evidence for elimination of immunomodulatory substances
36. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammatorion
37. Anterior pituitary and thyroid response after trauma. Modifying factors
38. High serum procalcitonin concentrations in patients with sepsis and infection
39. Procalcitonin in diagnosis of severe infection
40. Short half-life proteins and cholesterol in septic patients: Inflammatory or nutritional markers?
41. Serological reactions in pneumonia with mon-protein somatic fraction of Pneumococcus
42. Molecular and cellular control of the tissue-specific inflammatory response
43. Cytokines and acute phese proteins in rheumatoid arthritis
44. Validity of acute phase proteins as markers of disease activity
45. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit
46. Changes of acute phase proteins glycosylation profile as a possible prognostic marker in myocardial infarction
47. Metabolismo del hierro en el paciente crítico
48. Iron metabolism in elective surgery: The role of anaesthesia
49. Estado del hierro corporal en los pacientes en estado crítico: Significación de la ferritina sérica
50. Acutephase proteins in septic patients. Prognostic related utility and restriction
51. Inflammatory response in the early prediction of severity in human acute pancreatitis
52. Fibronectin fragments stimulate tumor necrosis factor secretion by human monocytes
53. Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system
54. Tumor necrosis factor impairs insulin action on perpheral glucose
55. Neuroendocrine and thyroid responses after trauma: Does head injury make and difference?
56. Lipids, lipoproteins and apoproteins in serum during infection
57. Soporte nutricional en la sepsis
58. Valor pronóstico de los parámetros bioquímicos en el síndrome de respuesta inflamatoria sistémica
59. Utilidad del colesterol como marcador nutrometabólico en el paciente séptico
60. Inflammatory markers: Superior predictors of adverse outcome in blunt trauma patients?
61. Serum cholesterol and cáncer in the NHANES I epidemiologic follow-up study
62. Prognostic significance of serum cholestrol in nursing home men
63. Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients
64. The liver in the induction and regulation of the acute stress response
65. Increased plasma concentrations of serum amyloid A: An indicator of the acute-phase response after cardiopulmonary bypass
66. Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis
67. Peroxidación lipídica en enfermos críticos
68. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation
69. Opioid systems and stress
70. Síndrome de respuesta inflamatoria sistémica (SRIS) y disfunción orgánica
71. Response of critically ill patients to incresed oxygen demand: Hemodynamic subsets
72. Decálogo de normas para la utilización de antibióticos en pacientes críticos
73. Nutritional and metabolic support: Converging concepts
74. Síndrome de distrés respiratorio agudo. Soporte nutro-metabólico
75. Interaction between nutrients, pro-inflammatory cytokines and inflammation
76. Early postoperative enteral immunonutrition: Clinical outcome and costcomparison analysis in surgical patients
77. Nitric oxide in inflammation and immunity
78. Molecular biology in the intensive care unit: A fragmework for interpretation
79. Insulin-like growth factors
80. Growth hormone and insulin-like growth factors in critical illness
81. Hormonas, factores de crecimiento y fármacos en el metabolismo y la nutrición
82. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies
83. New therapeutic approaches in sepsis: A critical review
84. Continuous veno-venous hemofiltration with dyalisis removes cytokines from the circulation of septic patients
85. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF-alfa plasma concentration
86. Influence of continuous hemofiltration on the hemodynamics of trauma patients
87. Anti-inflammatory therapies to treat sepsis and septic schock: A reassessment